Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Ludwig

Showing results (301-310 of 307) with videos related to

Pageof 31
Sort By:
You have reached the last page of results.This site can display upto 307 results.
Molecular Cancer Therapeutics|March 16, 2005
Targeting the platelet-derived growth factor receptor alpha with a neutralizing human monoclonal antibody inhibits the growth of tumor xenografts: implications as a potential therapeutic targetNick Loizos, Yan Xu, Jim Huber, et al.
Head & Neck|March 18, 2023
Tumor immune microenvironment alterations using induction cetuximab in a phase II trial of deintensified therapy for p16-positive oropharynx cancerJoshua D Smith, Megan L Ludwig, Apurva D Bhangale, et al.
Cancer Immunology Research|September 3, 2020
Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor ImmunityHelen Kotanides, Yiwen Li, Maria Malabunga, et al.
Human Antibodies|December 16, 2004
Conservation of receptor antagonist anti-tumor activity by epidermal growth factor receptor antibody expressed in transgenic corn seedDale L Ludwig, Larry Witte, Daniel J Hicklin, et al.
Science Translational Medicine|July 16, 2025
Systemic administration of an RNA binding and cell-penetrating antibody targets therapeutic RNA to multiple mouse models of cancerElias Quijano, Diana Martinez-Saucedo, Zaira Ianniello, et al.
BMJ Open|November 16, 2021
Which outcomes are most important to measure in patients with COVID-19 and how and when should these be measured? Development of an international standard set of outcomes measures for clinical use in patients with COVID-19: a report of the International Consortium for Health Outcomes Measurement (ICHOM) COVID-19 Working GroupWilliam H Seligman, Luz Fialho, Nick Sillett, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 11, 2022
Morphological, cellular, and molecular basis of brain infection in COVID-19 patientsFernanda Crunfli, Victor C Carregari, Flavio P Veras, et al.
Pageof 31

Showing results (301-310 of 307) with videos related to

Sort By:
Pageof 31
You have reached the last page of results.This site can display upto 307 results.
Molecular Cancer Therapeutics|March 16, 2005
Targeting the platelet-derived growth factor receptor alpha with a neutralizing human monoclonal antibody inhibits the growth of tumor xenografts: implications as a potential therapeutic targetNick Loizos, Yan Xu, Jim Huber, et al.
Head & Neck|March 18, 2023
Tumor immune microenvironment alterations using induction cetuximab in a phase II trial of deintensified therapy for p16-positive oropharynx cancerJoshua D Smith, Megan L Ludwig, Apurva D Bhangale, et al.
Cancer Immunology Research|September 3, 2020
Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor ImmunityHelen Kotanides, Yiwen Li, Maria Malabunga, et al.
Human Antibodies|December 16, 2004
Conservation of receptor antagonist anti-tumor activity by epidermal growth factor receptor antibody expressed in transgenic corn seedDale L Ludwig, Larry Witte, Daniel J Hicklin, et al.
Science Translational Medicine|July 16, 2025
Systemic administration of an RNA binding and cell-penetrating antibody targets therapeutic RNA to multiple mouse models of cancerElias Quijano, Diana Martinez-Saucedo, Zaira Ianniello, et al.
BMJ Open|November 16, 2021
Which outcomes are most important to measure in patients with COVID-19 and how and when should these be measured? Development of an international standard set of outcomes measures for clinical use in patients with COVID-19: a report of the International Consortium for Health Outcomes Measurement (ICHOM) COVID-19 Working GroupWilliam H Seligman, Luz Fialho, Nick Sillett, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 11, 2022
Morphological, cellular, and molecular basis of brain infection in COVID-19 patientsFernanda Crunfli, Victor C Carregari, Flavio P Veras, et al.
Pageof 31